These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4283571)

  • 1. [Urokinase inhibitor in human tonsils (author's transl)].
    Sasaki Y; Horiuchi K
    Josai Shika Daigaku Kiyo; 1974; (3):221-5. PubMed ID: 4283571
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of arterial thrombosis successfully treated with a large dosage of urokinase--study on urokinase administration with special reference to alpha2-plasmin inhibitor (author's transl)].
    Hayashi S; Yamada K
    Rinsho Ketsueki; 1979 Apr; 20(4):400-9. PubMed ID: 156270
    [No Abstract]   [Full Text] [Related]  

  • 3. [Different reactivity of UK- and SK-activated plasmin against two fluorogenic substrates for plasmin (author's transl)].
    Suzuki K; Nishioka J; Hashimoto S
    Nihon Ketsueki Gakkai Zasshi; 1981 May; 44(3):690-8. PubMed ID: 6460414
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of Immunoassay of Urinary urokinase inhibitor using biological binding activity of urokinase and urokinase inhibitor (author's transl)].
    Yoshio T; Kan S; Ninagawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr; 34(4):451-9. PubMed ID: 7040569
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activation of plasminogen and prothrombin by immobilized activators -- urokinase and thromboplastin (author's transl)].
    Rybák M; Coupek J
    Cas Lek Cesk; 1980 Oct; 119(40-41):1106-8. PubMed ID: 7026035
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined use of heparin and urokinase in the patients with nephritis resistant to the conventional treatment and the significance of alpha 2-plasmin inhibitor in the therapy (author's transl)].
    Koitabashi Y; Maruyama T; Ikoma M; Miyaji Y; Yamada K; Shimizu K
    Rinsho Ketsueki; 1982 Mar; 23(3):309-18. PubMed ID: 7050462
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assay method for urinary urokinase using synthetic fluorogenic substrate (author's transl)].
    Suzuki K; Nishioka J; Hashimoto S
    Rinsho Byori; 1979 Mar; 27(3):218-22. PubMed ID: 439470
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on quantitative determination of urokinase by radioimmunoassay and its clinical application. Part I. A new radioimmunoassay method for the quantitative determination of urokinase in urine (author's transl)].
    Wakayama Y
    Nihon Ketsueki Gakkai Zasshi; 1975 Oct; 38(5):582-8. PubMed ID: 1243728
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on (14)C-labeling of urokinase with (14)C-acetic anhydride (author's transl)].
    Tanaka Y; Moriyama S; Sasaki K
    Radioisotopes; 1980 Oct; 29(10):490-2. PubMed ID: 7025114
    [No Abstract]   [Full Text] [Related]  

  • 10. [Purification and characterization of fibrin-binding urokinase (author's transl)].
    Sumi H; Mihara H; Toki N
    Nihon Ketsueki Gakkai Zasshi; 1981 Sep; 44(5):1044-9. PubMed ID: 7036636
    [No Abstract]   [Full Text] [Related]  

  • 11. [The contamination with coagulative substance in urokinase preparation (author's transl)].
    Shiba T; Igarashi M; Hirose K; Takeuchi S; Awazu S; Asada T
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):537-40. PubMed ID: 495012
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies of tonsillitis from the aspect of protease-antiprotease. 2. Substances relation to fibrinolysis in tonsillar tissue of man (author's transl)].
    Kosugi T; Hamaya M
    Nihon Jibiinkoka Gakkai Kaiho; 1978 Apr; 81(4):349-57. PubMed ID: 660336
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
    Sprague LD; Tomaso H; Mengele K; Schilling D; Bayer C; Stadler P; Schmitt M; Molls M
    Oncol Rep; 2007 May; 17(5):1259-68. PubMed ID: 17390074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The estimation method for plasminogen content using fibrin plate with urokinase (author's transl)].
    Horie N; Okamoto U
    Rinsho Byori; 1976; 24(10):842-6. PubMed ID: 1033383
    [No Abstract]   [Full Text] [Related]  

  • 16. [Urokinase therapy in diabetic retinopathy (author's transl)].
    Kojima K; Suzuki M; Ichikawa H; Ichikawa K; Torii F; Sato Y; Oguri T; Yamaguchi Y; Kobayashi M; Asanuma H
    Nippon Ganka Gakkai Zasshi; 1981 Dec; 85(12):2108-14. PubMed ID: 7044071
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the fibrinolytic therapy in the patients with nephrotic syndrome (author's transl)].
    Shibata M; Shimizu K; Kishi T; Kobayashi K; Sakai H; Sugiyama H; Oguri M
    Nihon Jinzo Gakkai Shi; 1980 Sep; 22(9):1197-207. PubMed ID: 6450847
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y; Hayashi Y; Imai Y; Itoh H
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood coagulation tissue factors in human palatine tonsils].
    Rybina OF
    Vestn Otorinolaringol; 1973; 35(2):61-3. PubMed ID: 4267486
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urokinase (in situ) in the case of acute ischemia of the lower limbs (author's transl)].
    Paillot J; Dumontier P; Raynov M; Ott B; Benichoux R
    J Mal Vasc; 1981; 6(1):19-22. PubMed ID: 7026712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.